Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer - Wikidata - wikimedia - TriplyDB

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

http://www.wikidata.org/entity/Q28262255

about

Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody Prostate stem cell antigen: a Jekyll and Hyde molecule?Smart polymeric nanoparticles for cancer gene delivery.Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells.Engineered T cells for pancreatic cancer treatment Looking to the future: biomarkers in the management of pancreatic adenocarcinoma.Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots Prostate stem cell antigen gene is expressed in islets of pancreas.Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.Prostate stem cell antigen: a prospective therapeutic and diagnostic target.Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.Dendritic-cell vaccination for prostate cancer.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.Applications of microarray technology to pancreatic cancer research and drug development.Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population.Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells.CAR T-cell therapy for pancreatic cancer.Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis.Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options.PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.Adaptation of impression cytology to enable conjunctival surface cell transcriptome analysis.Prostate stem cell antigen is expressed in normal and malignant human brain tissues.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?

P2860

Q26778234-738B597A-E37C-4368-B297-667A8BAAEDDC Q28483778-8E031878-681E-45CF-8460-987A42335FEC Q33491567-AF03DBC0-10AF-41C5-8805-AFC645CE2A31 Q33550600-574373BB-5CA9-4BD6-8C94-C99CACBC3E27 Q33640235-F057B0A5-2CD1-4FAB-B1E4-18547DAA5337 Q33738280-88B3F6F1-6240-4A56-8864-051B387AC67F Q34001130-182C643E-415A-4853-A5A9-08504FDC613C Q35057532-186BC9A2-8E01-4420-8F10-D5717CD936B2 Q35082285-E8574E6D-602A-42B0-89FD-76FC20640C16 Q35244233-77ADB5F4-CC88-44D5-8110-99696C82256E Q35297202-E0316B57-6777-48F6-A94C-F12D7F11F098 Q35882541-8F94AD4C-C92C-4694-BF5E-D367DCF75AEC Q35965742-86A6D88C-3DA9-4F40-A74E-363B94C3DC29 Q36319922-90F6ECD3-7550-4AC8-8FD2-C35997E28CAE Q36485336-8E81506B-6964-4630-AB2E-689A6925D3C9 Q36507544-BC9C49C2-F0AF-4AA3-A8CB-522D96609863 Q36536212-94D627C1-D653-4A97-A46A-111E1643926D Q37026797-B5B33305-2020-4C37-B117-27ED596E1FAF Q37104978-FDC347E1-D0C4-49E7-9F05-98AEB5AB8247 Q37186552-3D4E4339-B81A-4726-BE26-6CBE19D64437 Q37557813-BFB309F7-5E04-45FD-8F5F-7B35DB1FF866 Q37773277-80809CBD-283D-42EE-B57D-6926232FBFD1 Q37978315-31E4EF43-5102-4386-B349-75D230B44376 Q38089806-A30B8884-B14B-455D-8702-DDDDE807A9F6 Q38168921-BADD036F-DD8C-436F-ABA2-00556C95011D Q38608986-E9BC3F97-2A87-4553-892B-65DD550B660D Q38699173-C2081F2A-897F-4491-9922-F9A5CF86FB99 Q38711222-548C9516-8290-4EFB-B363-816FA24092F3 Q38719148-88A1A290-B9EB-418E-AD56-7DFF5A2D7220 Q39064900-D9B4F9AD-BF55-4FAF-BB5A-35F645F634FA Q39201000-B8C6576A-0D44-4018-A810-138691AA22E5 Q39202440-DB0116C2-F044-4CA5-B6BD-F788C426036A Q41613017-9C535CC8-C5A0-4B48-8C99-4B2F0F11111B Q43138752-BE602CA6-0D14-4B65-B030-35DAD0C1F5A1 Q46201624-AAF1227F-F2AC-422F-997C-DF1CC8D10D4B Q46834579-3D9D6BC5-D32D-4978-BAB6-6D039C5F9123 Q50053295-3D3DDD95-C7C0-4D5C-8EA3-F63CC1869024 Q52739894-760454F6-B67D-4EF8-8E47-46F7A5C3C494

P2860

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

http://www.wikidata.org/entity/Q28262255

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@ast

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@en

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@nl

type

label

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@ast

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@en

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@nl

prefLabel

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@ast

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@en

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@nl

P1433

Q28262255-EA58F16D-C173-4FD0-BB64-DD281468303D

P1476

Q28262255-25EDFFE3-D8FF-42A7-9D17-395DF97B89EB

P2093

Q28262255-1F72418D-09C5-4791-AA4F-0C09152C08C5

Q28262255-3C04E174-536D-46CA-94EF-EE3670196745

Q28262255-3C2A6A9A-20D2-4CD7-9F4F-85AD92F97102

Q28262255-77B33789-309C-4C49-8059-507297395AFF

Q28262255-8DEC75FD-F328-4690-98C8-617EA3D12EEB

Q28262255-AE538E94-12D3-41A8-84F9-A14CECDEB673

Q28262255-B0F044A5-573A-41BD-8BE2-76E7A2AEC5C3

Q28262255-DE5064ED-65BA-4D57-B7F9-5F12B1523650

P304

Q28262255-9A4DF458-A09E-4930-841A-8311D51F6363

P31

Q28262255-C196C044-DCEF-46C8-B6C4-482608DD06AF

P356

Q28262255-DFA43D2E-75D8-4AC6-AFF8-FF5FDD23D804

P407

Q28262255-1D45358D-55FE-4792-B56A-FC2AC84ED095

P433

Q28262255-A3E409B4-841E-4942-A909-4D868F813D31

P478

Q28262255-F6B93012-F4AE-4F9F-8814-480A8D62C098

P50

Q28262255-098148F6-DB9C-481E-86A4-4E0EE2044BAE

Q28262255-48E92FBD-F474-434E-9A14-E9B01E9E3B9B

P577

Q28262255-E686FEF1-A71B-4643-8CD9-22BFA9C45FEB

P698

Q28262255-401D5032-660A-4B11-84A4-2ECB1C19E2F0

P921

Q28262255-E78D2A05-C7C9-4352-A415-8F7F7443B020

P356

01.MPA.0000173459.81193.4D

P1433

P1476

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

@en

P2093

Anjali Jain

http://www.w3.org/2001/XMLSchema#string

Evelyn Kono

http://www.w3.org/2001/XMLSchema#string

Howard A Reber

http://www.w3.org/2001/XMLSchema#string

Moritz N Wente

http://www.w3.org/2001/XMLSchema#string

Oscar J Hines

http://www.w3.org/2001/XMLSchema#string

Pascal O Berberat

http://www.w3.org/2001/XMLSchema#string

Robert E Reiter

http://www.w3.org/2001/XMLSchema#string

Thomas Giese

http://www.w3.org/2001/XMLSchema#string

P304

119-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MPA.0000173459.81193.4D

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Markus Büchler

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16024997

http://www.w3.org/2001/XMLSchema#string

P921